A $700,000 JEPQ position clears a $75,000 retirement budget today, but inflation-adjusted withdrawals over a decade expose a flaw baked into the fund's design that monthly distributions alone cannot fix.
Retirees anchoring budgets to JEPI's latest monthly check are making a math mistake that costs real money, and the actual income story looks nothing like the number circulating in income forums right now.
An $800,000 stake in SPYI looks like the perfect bridge to Social Security at 67, but the math behind a simple $8,000 monthly withdrawal tells a far more uncomfortable story about sequence risk and…
A 15-year scorecard just revealed how badly active dividend fund managers fared against a passive benchmark, and the results raise a pointed question about whether the most popular dividend ETF belongs in your portfolio…
Federal agencies can sign contracts for Microsoft's new AI government tier starting October 1, but key features may not arrive until later. Whether that gap kills the deal before it starts reveals something uncomfortable…
Meta's new AI shopping agent can place orders on a shopper's behalf without them ever visiting a merchant's website, and Shopify sits right in the middle of that transaction flow. Whether that position is…
Amazon just acquired the team behind a wildly popular open-source analytics engine, but the code stays free for Microsoft, Google, and every other rival to use. So what exactly did Amazon buy, and can…
Three new names are entering the S&P 500, swapping out brewers and homebuilders for fuel-cell technology and genomics, but whether that trade actually benefits VOO holders depends on a math problem most investors overlook.
Credo's AI connectivity business is growing at a triple-digit pace, but the gap between its reported profit and actual cash generation raises a question every investor in the stock needs to answer before the…
OpenAI's CFO just revealed how $122 billion in cash fundamentally changes the power dynamic between the world's most important AI lab and its chip suppliers, and the implications for Nvidia's premium pricing are only…
Bank of America's finance chief went on air to calm investors while the stock quietly slid into its worst month in over a year. The reassurance he offered answers a different question than the…
Long Treasury yields just hit levels not seen since 2007, and the usual rescue plan from the Fed is nowhere on the horizon. Understanding why this time is structurally different matters for anyone still…
The White House's top economist built a statistical case that inflation is already dead, presented it as a hypothetical dissenter's argument, then handed it to no one. Whether the Fed agrees tomorrow determines what…
ASML's $400 million lithography machine powers every cutting-edge AI chip on the planet, yet one stubborn physical constraint keeps chipmakers stitching together workarounds that quietly erode margins. The fix exists on paper, but the…
Tesla is staging a Roadster reveal nearly nine years after reservation holders paid full price for a car that still does not exist, and this time the audience has already stopped believing in promises.
Amazon just booked six more rockets and locked in enterprise deals with Delta, JetBlue, and Vodafone, yet Starlink still holds advantages that launch contracts alone cannot solve.
Washington is drafting legislation that could give federal regulators the power to block Google's most powerful AI models before they ever reach customers, and the financial consequences for Alphabet's $460 billion Cloud backlog are…
Nvidia is letting a rival chipmaker plug directly into its own racks, and the move only looks like a concession until you follow the money through every layer of the data center.
California just banned the design patterns that power Meta's ad engine for millions of young users, and the real question for shareholders is what happens when other states follow.
A landmark trial just proved semaglutide can pull children as young as six below the obesity threshold, yet Wall Street shrugged and the real battle over who pays, who prescribes, and whether society is…
